医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

L&T Technology Services Ltd Develops the World’s First Cost-Effective Robotic Endo-Training Kit

2019年12月16日 PM08:15
このエントリーをはてなブックマークに追加


 

BANGALORE, India

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), India’s leading pure-play engineering services company, was felicitated for its Robotic Endo-training Kit at the 8th Foundation Day of Global Innovation & Technology Alliance (GITA) on Thursday, 28th November 2019 at Hotel Le Meridien, New Delhi.

Hon’ble Minister of Science & Technology, Health and Family Welfare and Earth Sciences Dr. Harsh Vardhan was the Chief Guest, Prof. K. Vijay Raghavan, Principal Scientific Advisor (PSA) to the Government of India and Prof. Ashutosh Sharma, Secretary, Department of Science & Technology, were the Guests of Honour.

LTTS was recognized for developing the world’s first cost-effective Robotic Endo-training Kit, in association with GITA and Department of Science and Technology (DST). The research and development for the kit has been a joint effort between India and the Republic of Korea.

LTTS’ Robotic Endo-training Kit is a futuristic surgical training robot that gives a high-definition observation of the patient’s anatomy and the instruments – Master Tool Manipulator, Patient Side Manipulator, Endoscopic Camera Arm, Liver VR Feed – have a seven-degree range of movements to improve the precision of surgical techniques. This kit is made at a low cost and hence it can be used by many hospitals or even in smaller clinics to train on inanimate material.

Dr. Ramalingam, one of the country’s foremost Laparoscopic Urologists, has been a guide and mentor from the inception of the project, and was instrumental in making it a success.

Mr. Muralidhara Hosahalli, Global Head of Medical & Life Sciences at L&T Technology Services said, “LTTS’ Robotic Endo-training Kit is a state-of-the-art technology that offers superior vision, improved flexibility, greater accuracy and ergonomic support to surgeons. Through this association with GITA and the Department of Science and Technology we have been able to contribute towards the massive technological shift that is transforming the Indian healthcare industry. Evolving technology is the need of the hour and LTTS’ Robotic Endo-trainer kit helps surgeons to get trained in carrying out most of the complex operations with great precision, flexibility and power as compared to conventional methods.”

Ms Ratika Jain, CEO, GITA said, “One of our objectives is to analyze and promote evolving technologies available globally in partnership with global corporates who are leaders in technology. The strategic collaboration with L&T Technology Services on the Robotic Endo-Trainer is part of our vision to strengthen India’s innovation ecosystem. We believe such collaborations are the basis for a more sustainable, technologically advanced and economic development and thank LTTS for lending their rich domain expertise in engineering medical devices.”

About L&T Technology Services Ltd

L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 51 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 16,700 employees spread across 17 global design centers, 28 global sales offices and 49 innovation labs as of September 30, 2019.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191216005314/en/

CONTACT

Aniruddha Basu

L&T Technology Services Limited

E: Aniruddha.Basu@LTTS.com

T: +91-80-67675173

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)